📖
Molecular Therapies for Inherited Retinal Diseases
DOAB Contributor

Molecular Therapies for Inherited Retinal Diseases

Author / Organization:
Open Access Books Published 2021 Verification Pending

Overview & Synopsis

Following the implementation of next-generation sequencing technologies (e.g., exome and genome sequencing) in molecular diagnostics, the majority of genetic defects underlying inherited retinal disease (IRD) can readily be identified. In parallel, opportunities to counteract the molecular consequences of these defects are rapidly emerging, providing hope for personalized medicine. ‘Classical’ gene augmentation therapy has been under study for several genetic subtypes of IRD and can be considered a safe and sometimes effective therapeutic strategy. The recent market approval of the first retinal gene augmentation therapy product (LuxturnaTM, for individuals with bi-allelic RPE65 mutations) by the FDA has not only demonstrated the potential of this specific approach, but also opened avenues for the development of other strategies. However, every gene—or even every mutation—may need a tailor-made therapeutic approach, in order to obtain the most efficacious strategy with minimal risks associated. In addition to gene augmentation therapy, other subtypes of molecular therapy are currently being designed and/or implemented, including splice modulation, DNA or RNA editing, optogenetics and pharmacological modulation. In addition, the development of proper delivery vectors has gained strong attention, and should not be overlooked when designing and testing a novel therapeutic approach. In this Special Issue, we aim to describe the current state of the art of molecular therapeutics for IRD, and discuss existing and novel therapeutic strategies, from idea to implementation, and from bench to bedside.

Indexed from repository: Directory of Open Access Books (www.doabooks.org)

Document Information

Document Title Molecular Therapies for Inherited Retinal Diseases
Author / Organization DOAB Contributor
Subject & Discipline induced pluripotent stem cell (iPSC)
Categories Open Access Books
Publication Year 2021
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website Directory of Open Access Books (www.doabooks.org)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-174219
Original Source Link Visit Source Page on www.doabooks.org »